The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Johnson David Lee since 2019.
This trader's CIK number is 1733883.
At the time of last reporting, Johnson David Lee was the Chief Commercial Officer of Global Blood Therapeutics, Inc.. (stock ticker symbol GBT).
Also see all insider trading activities at Global Blood Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | GBT | 0 | $0 | 0 | $0 | 25,649 | $0 |
| 2021 | GBT | 0 | $0 | 0 | $0 | 25,052 | $0 |
| 2020 | GBT | 0 | $0 | 0 | $0 | 18,645 | $0 |
| 2019 | GBT | 0 | $0 | 0 | $0 | 16,250 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-09-01 | GBT | Option Ex | 4,971 | .00 | 0 |
| 2022-08-01 | GBT | Option Ex | 6,770 | .00 | 0 |
| 2022-04-01 | GBT | Option Ex | 4,375 | .00 | 0 |
| 2022-03-01 | GBT | Option Ex | 2,763 | .00 | 0 |
| 2022-02-01 | GBT | Option Ex | 6,770 | .00 | 0 |
| 2021-10-01 | GBT | Option Ex | 4,375 | .00 | 0 |
| 2021-09-01 | GBT | Option Ex | 2,762 | .00 | 0 |
| 2021-08-01 | GBT | Option Ex | 6,770 | .00 | 0 |
| 2021-04-01 | GBT | Option Ex | 4,375 | .00 | 0 |
| 2021-02-01 | GBT | Option Ex | 6,770 | .00 | 0 |
| 2020-10-01 | GBT | Option Ex | 4,375 | .00 | 0 |
| 2020-08-01 | GBT | Option Ex | 6,770 | .00 | 0 |
| 2020-04-01 | GBT | Option Ex | 4,375 | .00 | 0 |
| 2020-02-01 | GBT | Option Ex | 3,125 | .00 | 0 |
| 2019-10-01 | GBT | Option Ex | 4,375 | .00 | 0 |
| 2019-08-01 | GBT | Option Ex | 3,125 | .00 | 0 |
| 2019-04-01 | GBT | Option Ex | 8,750 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Johnson David Lee (Chief Commercial Officer of Global Blood Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.